Barr Launches Generic Actiq
Barr Pharmaceuticals Inc. launched a generic version of Cephalon Inc.'s Actiq cancer pain reliever on Wednesday after an agreement with antitrust authorities gave Barr the license to make and sell the...To view the full article, register now.
Already a subscriber? Click here to view full article